Recent Transactions

16-Dec-11
$NA
United States flag
Target: 

ISTA Pharmaceuticals, Inc.

Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its defense against an unsolicited offer from Valeant Pharmaceuticals and on its review of strategic alternatives

08-Dec-11
$NA
United States flag
Target: 

US Department of Energy

Advised Herb Allison in an independent review of a $35.9 billion energy loan portfolio

21-Nov-11
$689 million
Australia flag
Target: 

iNova Pharmaceuticals

United States flag
Acquiror: 
Valeant Pharmaceuticals

Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals

07-Nov-11
$398 million
United States flag
Target: 

American Dental Partners, Inc.

United States flag
Acquiror: 
JLL Partners

Advised American Dental Partners, Inc. (NASD: ADPI), one of the nation’s leading business partners to dental group practices, on its sale to JLL Partners, a leading private equity firm

10-Oct-11
$3.2 billion
United States flag
Target: 

Complete Production Services

United States flag
Acquiror: 
Superior Energy Services

Advised Superior Energy Services on its acquisition of Complete Production Services, a leading provider of oilfield services in North America

14-Jul-11
$340 million
United States flag
Target: 

Edge Oilfield Services

United States flag
Acquiror: 
Key Energy Services, Inc.

Advised Key Energy Services, the largest onshore, rig-based well servicing contractor, on its acquisition of Edge Oilfield Services, a provider of onshore oilfield rental equipment

30-Jun-11
$609 million
Japan flag
Target: 

Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion

United States flag
Acquiror: 
Royalty Pharma

Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion

20-Jun-11
$2.0 billion
Canada flag
Target: 

Capital Power Income L.P.

United States flag
Acquiror: 
Atlantic Power Corporation

Advised Capital Power Income L.P., a Canadian power trust with a portfolio of 20 power generation assets located in Canada and the United States (total net generating capacity of 1,400 MW), on its sale to Atlantic Power Corporation

16-Jun-11
$288 million
United States flag
Target: 

Imperial Palace Casino Resort and Spa

United States flag
Acquiror: 
Boyd Gaming Corporation

Advised Boyd Gaming Corporation, a leading gaming operator in Nevada, the Midwest and South, on the acquisition of Imperial Palace Casino Resort and Spa in Biloxi, Mississippi

04-Feb-11
$420 million
United States flag
Target: 

Bosque Power Company

Advised Bosque Power Company, a natural gas-fired power plant located in Texas, on its negotiations with lenders and restructuring

15-Dec-10
$12.9 billion
U.S.A., Swiss flags
Target: 

Alcon, Inc.

Switzerland flag
Acquiror: 
Novartis AG

Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company

15-Dec-10
$4.6 billion
United States flag
Target: 

Dynegy Inc.

United States flag
Acquiror: 
Icahn Enterprises LP

Advised Dynegy Inc., an independent power producer, on its sale to Icahn Enterprises LP in an all-cash transaction

07-Dec-10
$500 million
United States flag
Target: 

Medicity, Inc.

United States flag
Acquiror: 
Aetna Inc.

Advised Aetna Inc. on its acquisition of Medicity, Inc., a leading provider of technology solutions to enable the secure access and exchange of healthcare information

09-Nov-10
$27.0 billion
United States flag
Target: 

General Growth Properties Inc.

Advised the 2006 Credit Facility Lenders, the largest class of unsecured debt with claims in excess of $2.8 billion, in connection with the Chapter 11 proceedings of mall REIT GGP, which resulted in cash payoff of the facilities in full

12-Jul-10
$NA
United States flag
Target: 

Breast Care Business of Ethicon-Endo Surgery

United States flag
Acquiror: 
Devicor Medical Products, Inc. (a GTCR portfolio company)

Advised GTCR and Devicor Medical Products, Inc., a portfolio company of GTCR, on the acquisition of the Breast Care Business of Ethicon-Endo Surgery

30-Jun-10
$820 million
U.S.A., Canada flags
Target: 

Trident Resources Corporation

Advised Chilton Investment Company on Trident’s financial restructuring and emergence from CCAA / Chapter 11 bankruptcy protection including the negotiation of a new equity investment

10-Jun-10
$580 million
United States flag
Target: 

Tishman Speyer Washington D.C. Portfolio

Advised term loan and credit facility lenders to the Tishman Speyer partnership holding a portfolio of 28 office buildings in Washington D.C. and the surrounding area on a restructuring which resulted in payoff of the facilities in full

05-Apr-10
$225 million
United States flag
Target: 

Medegen, Inc

United States flag
Acquiror: 
CareFusion Corporation

Advised Medegen, Inc., a medical device company that develops, manufactures and markets clinically superior disposable intravenous therapy products on its sale to CareFusion, a global medical devices company

03-Mar-10
$NA
Mexico flag
Target: 

Puerta Mexico Transportation Facility

United States flag
Acquiror: 
Kansas City Southern

Advised Ports America, Inc., a portfolio company of Highstar Capital, on its sale of Puerta Mexico, a state-of-the-art customs-clearing intermodal transportation facility located in the Mexico City market

23-Feb-10
$NA
United States flag
Target: 

Heartscape Technologies, Inc.

United States flag
Acquiror: 
Roper Industries, Inc.

Advised Heartscape Technologies, a medical device company on its sale of substantially all its assets to Roper Industries, a diversified growth company

09-Nov-09
$327 million
United States flag
Target: 

Enzon Pharmaceuticals, Inc.

Italy flag
Acquiror: 
Sigma-Tau Pharmaceuticals

Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company

31-Aug-09
$5.5 billion
United States flag
Target: 

BJ Services Company

United States flag
Acquiror: 
Baker Hughes Incorporated

Advised BJ Services Company, a leading pressure pumping company, on its merger with Baker Hughes Incorporated, a global oilfield services company

10-Aug-09
$1.5 billion
United States flag
Target: 

Dynegy, Inc.

United States flag
Acquiror: 
LS Power Equity Partners

Advised Dynegy, Inc., a merchant power generator, on its sale of 9 power plants to LS Power Equity Partners in exchange for cash and Dynegy shares

23-Jun-09
$155 million
United States flag
Target: 

Monogram Biosciences, Inc.

United States flag
Acquiror: 
Laboratory Corporation of America Holdings

Advised LabCorp on the acquisition of Monogram Biosciences, a molecular diagnostics company focused on guiding and improving the treatment of serious infectious diseases and cancer

12-Mar-09
$46.9 billion
United States flag
Target: 

Genentech, Inc.

Switzerland flag
Acquiror: 
Roche Holding Ltd.

Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company

Pages

show all